Giardiasis in an Infant With Fibrosarcoma: A Case Report.

Q3 Pharmacology, Toxicology and Pharmaceutics Infectious disorders drug targets Pub Date : 2023-01-01 DOI:10.2174/1871526523666230713141153

Twishi Shrimali, Saumya Srivastava, Naila Mohammad, Nikhil John, Vibhor Tak, Rahul Saxena

{"title":"Giardiasis in an Infant With Fibrosarcoma: A Case Report.","authors":"Twishi Shrimali, Saumya Srivastava, Naila Mohammad, Nikhil John, Vibhor Tak, Rahul Saxena","doi":"10.2174/1871526523666230713141153","DOIUrl":null,"url":null,"abstract":"Introduction: Giardia lamblia is a neglected parasitic infection that typically affects the developing nations of the world. It is a microscopic intestinal parasite that is known to cause stomach cramps, bloating, nausea and bouts of diarrhoea.Case presentation: Here, we are presenting the case of a 1.5 years-old-baby with an immunocompromised condition who got infected by Giardia lamblia. The baby with fibrosarcoma was receiving treatment in our tertiary care centre, and later developed abdominal and minor systemic complaints. Stool samples were collected, which showed trophozoites and cysts of Giardia.Discussion: To the best of our knowledge, this is the first case of Giardia lamblia infection in a paediatric patient with fibrosarcoma. The patient improved after taking metronidazole for ten days.Conclusion: It is critical to keep a watch out for this neglected parasite, and suggested samples, particularly stool samples, must be sent for investigation in order to diagnose and manage these cases properly.","PeriodicalId":13678,"journal":{"name":"Infectious disorders drug targets","volume":"23 7","pages":"82-85"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious disorders drug targets","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1871526523666230713141153","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Giardia lamblia is a neglected parasitic infection that typically affects the developing nations of the world. It is a microscopic intestinal parasite that is known to cause stomach cramps, bloating, nausea and bouts of diarrhoea.

Case presentation: Here, we are presenting the case of a 1.5 years-old-baby with an immunocompromised condition who got infected by Giardia lamblia. The baby with fibrosarcoma was receiving treatment in our tertiary care centre, and later developed abdominal and minor systemic complaints. Stool samples were collected, which showed trophozoites and cysts of Giardia.

Discussion: To the best of our knowledge, this is the first case of Giardia lamblia infection in a paediatric patient with fibrosarcoma. The patient improved after taking metronidazole for ten days.

Conclusion: It is critical to keep a watch out for this neglected parasite, and suggested samples, particularly stool samples, must be sent for investigation in order to diagnose and manage these cases properly.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

贾第虫病合并纤维肉瘤婴儿一例报告。

简介:贾第鞭毛虫是一种被忽视的寄生虫感染，通常影响世界的发展中国家。它是一种微小的肠道寄生虫，已知会导致胃痉挛、腹胀、恶心和腹泻。病例介绍:在这里，我们要介绍一个1.5岁的婴儿，免疫功能低下，感染了贾第鞭毛虫。患有纤维肉瘤的婴儿在我们的三级保健中心接受治疗，后来出现腹部和轻微的全身不适。收集粪便样本，发现滋养体和贾第鞭毛虫囊肿。讨论:据我们所知，这是首例小儿纤维肉瘤患者的贾第鞭毛虫感染病例。病人服用甲硝唑十天后病情好转。结论:对这一被忽视的寄生虫保持高度警惕，建议采集标本，特别是粪便标本进行调查，以便正确诊断和管理这些病例。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Infectious disorders drug targets Pharmacology, Toxicology and Pharmaceutics-Pharmacology

CiteScore

3.10

自引率

0.00%

发文量

123

期刊介绍： Infectious Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in infectious disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in infectious disorders. As the discovery, identification, characterization and validation of novel human drug targets for anti-infective drug discovery continues to grow, this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.